Islet cell autoantibody levels after the diagnosis of young adult diabetic patients
- 24 August 2007
- journal article
- Published by Wiley in Diabetic Medicine
- Vol. 24 (11) , 1221-1228
Abstract
Aims The aim was to determine the course of islet cell antibodies [glutamate decarboxylase (GADA), tyrosine phosphatase‐like islet antigen 2 (IA‐2A) and islet cell (ICA)] after the diagnosis of the diabetic patient. Methods The Diabetes Incidence Study in Sweden (DISS) attempted to prospectively enrol all newly diagnosed diabetic patients aged 15–34 years during 1992 and 1993. C‐peptide and autoantibody levels were determined from venous blood samples at diagnosis and again at yearly intervals for 6 years. Results After the first year, the odds of remaining GADA positive decreased by 9% per year [odds ratio (OR) = 0.91, 95% confidence interval (CI) = 0.85–0.96] while the mean GADA index remained unchanged ( = 0.8, P = 0.37). There was no change in the percentage of subjects testing IA‐2A positive after the first year ( = 0.1, P = 0.75). However, the mean index decreased 0.04 per year (95% CI: 0.03–0.05)—a 7.9% decline (95% CI: 5.4–10.4%). The odds of a subject testing positive for ICA decreased by 24% per year (OR = 0.76, 95% CI = 0.70–0.82). The mean ICA levels decreased 0.75 per year (95% CI: 0.66–0.84)—a 16.4% decline (95% CI: 14.1–18.6%). The rate of change in titres for all three autoantibodies was independent of gender, human leucocyte antigen genotype and C‐peptide status. Conclusions GADA levels remained high while ICA levels declined. In contrast to a previous study, we found that the proportion of IA‐2A subjects remaining positive did not decrease after the first year, while the average index decreased slightly.Keywords
This publication has 42 references indexed in Scilit:
- Glutamic Acid Decarboxylase Autoantibody Prevalence and Association with HLA Genotype in Patients with Younger-Onset Type 1 Diabetes and Proliferative Diabetic RetinopathyOphthalmology, 2005
- Islet antibodies and remaining β‐cell function 8 years after diagnosis of diabetes in young adults: a prospective follow‐up of the nationwide Diabetes Incidence Study in SwedenJournal of Internal Medicine, 2004
- Predictability of C‐peptide for autoimmune diabetes in young adult diabetic patientsPractical Diabetes International, 2001
- Combinations of Beta Cell Specific Autoantibodies at Diagnosis of Diabetes in Young Adults Reflects Different Courses of Beta Cell DamageAutoimmunity, 2001
- Prognostic Factors for the Course of Cell Function in Autoimmune DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2000
- HLA‐DR typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor‐recipient matching in cadaveric transplantationTissue Antigens, 1992
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990
- Epidemiology of Diabetes Mellitus in SwedenActa Medica Scandinavica, 1986
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986
- Islet-Cell-Surface Antibodies in Juvenile Diabetes MellitusNew England Journal of Medicine, 1978